This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Hiroshi Iwamura, PhD
Deputy Head of API Process Development Department at Chugai Pharmaceutical Co., Ltd.
Speaker

Profile

Hiroshi Iwamura is currently the Deputy Head of the API Process Development Department and leads chemical process R&D at Chugai Pharmaceutical Co., Ltd. Over the past 30 years in the pharmaceutical industry, he has developed a comprehensive skill set in API manufacturing and quality control strategy, pharmaceutical regulatory science, new technology development, and project management. Before joining Chugai in 2010, Dr. Iwamura worked as a process chemist at Mitsubishi Tanabe Pharma Corporation. He obtained his Ph.D. from Kyoto University under the supervision of Prof. Tamio Hayashi and Prof. Donna G. Blackmond, focusing on reaction kinetics analysis.

Agenda Sessions

  • Sustainability Challenge in Cyclic Peptide Synthesis: The Power of Crystallization and CSPS

    9:50am
  • Development of an Efficient and Scalable CSPS Process for a Mid-Sized Cyclic Peptide

    1:45pm